diabetesjain.com 

                Monitoring & follow up

Home
Patient Education
Organization
Consultations
Diabetes
Hypertension
Lipid disorder
Thyroid
Arthritis
Fever
Weight Reduction
Asthma over view
Jaundice Hepatitis A
Sleep disorders
Cardiac markers
CT MRI Xray
Discounts Lab tests
Free camps
For Patients
For Doctors
Pharma companies
For students
For schools
Life Insurance
Alerts
Visitor page
Donate
About us
Disclaimer
Feed back

[Up] [Hypothyroidism classification] [Risk factors] [Clinical features] [End organ impact] [Associated illnesses] [Diagnosis] [Treatment] [Dose titration] [Drug interactions] [Monitoring & follow up] [Myxedema coma]

 

 

Hypothyroidism needs life long treatment & patient compliance can' be an issue hence monitoring & follow up are important. 

 

 Adults

 Titration of dosage

bullet

Titration of dosage of thyroxin is done to maintain TSH in normal range of O.2-5 uIU/L and

bullet

In cases of central hypothyroidism to maintain T4 levels in normal range( 5- 13.5 ug/dl)

 

 Follow up 

bullet

Follow up of these patients is done with TSH testing at 6-8 weeks intervals. 

bullet

In severe hypothyroid patients, older patients or in young patients with a history of a cardiovascular disease, TSH testing is done at 3-6 weeks interval. 

bullet

In central hypothyroidism FT4 /T4 testing at 4-6 week intervals.

 

 Maintenance

bullet

Once the dose is titrated and TSH /T4 maintained within normal limits, patient should be followed up at 6 months or yearly intervals.

 

 Infants and Neonates

bullet

Serum T4 and TSH measurements should be evaluated at the following intervals, with subsequent dosage adjustment to normalize serum total T 4 or FT 4 and TSH.

bullet

2 and 4 weeks after the initiation of Thyroxin sodium treatment ;

bullet

Every 1 to 2 months during the first year of life;

bullet

Every 2 to 3 months between 1 and 3 years of age;

bullet

Every 3 to 12 months thereafter until growth is completed

bullet

Evaluation at more frequent intervals is advisable when compliance is poor or abnormal values are obtained. 

bullet

Patient evaluation is also advisable approximately 6 to 8 weeks after any change in Thyroxin sodium dose.

 

                                            Site designed and maintained by JMWDC                 Medical Web designing for doctors contact